Medimax
0810.891.591 · rovalta.com · 09/11/2026
ACTIVE
Medimax
Financial year 2025 · Closed on 31/12/2025
Net result41,1 k €+136,8 %over 1 year
Gross margin79,8 k €+82,6 %over 1 year
Equity250,6 k €+19,6 %over 1 year
Overview
Identity
Source · BCE/KBOMedimax is a Private limited company incorporated in 2009. Its registered office is in Genk.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0810.891.591
- Incorporation
- 02/04/2009
- Legal form
- Private limited company
- Registered office
- Caetsbeek 23
3600 Genk · FlandreSee on map - Contributed capital
- 6 200,00 €
- Latest accounts
- 31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 17 filingsTrend over 17 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 79,8 k € | +82.6% | 43,7 k € | +265% | 12 k € | -82.4% | 67,8 k € | +70.0% | 39,9 k € |
| EBITDA | 78,1 k € | +92.6% | 40,5 k € | +256% | 11,4 k € | -83.1% | 67,3 k € | +70.4% | 39,5 k € |
| Operating result | 62,7 k € | +120% | 28,5 k € | +620% | -5,5 k € | -111% | 50,8 k € | +112% | 24 k € |
| Net result | 41,1 k € | +137% | 17,4 k € | +380% | -6,2 k € | -119% | 33,4 k € | +131% | 14,5 k € |
| Balance sheet | |||||||||
| Equity | 250,6 k € | +19.6% | 209,5 k € | +9.0% | 192,1 k € | -3.1% | 198,3 k € | +20.2% | 164,9 k € |
| Total assets | 289,1 k € | +10.1% | 262,6 k € | +3.2% | 254,3 k € | -9.4% | 280,8 k € | +21.6% | 231 k € |
| Cash | 36,3 k € | +38.7% | 26,1 k € | +56.3% | 16,7 k € | -88.2% | 142,1 k € | +94.8% | 73 k € |
| Debts | 38,5 k € | -27.5% | 53,1 k € | -14.6% | 62,2 k € | -24.6% | 82,5 k € | +24.9% | 66,1 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20252 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Christel Thomassen | DirectorManager2019 accountsended | ||
Erik Maes | DirectorManager2019 accountsended |
Other companies at this address
Caetsbeek 23 3600 Genk| Company | CBE no. |
|---|---|
EMK Invest● Active | 0745.464.695 |
Zorgweb● Active | 1025.810.434 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 13/04/2026 | 05/08/2025 | 22/08/2024 | 27/03/2023 | 07/06/2022 | 05/07/2021 |
| General meeting | 17/03/2026 | 02/05/2025 | 03/05/2024 | 09/03/2023 | 06/05/2022 | 07/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 17 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 17/03/2026 | 13/04/2026 | Dutch | |
| Micro model | 31/12/2024 | 02/05/2025 | 05/08/2025 | Dutch | |
| Micro model | 31/12/2023 | 03/05/2024 | 22/08/2024 | Dutch | |
| Micro model | 31/12/2022 | 09/03/2023 | 27/03/2023 | Dutch | |
| Micro model | 31/12/2021 | 06/05/2022 | 07/06/2022 | Dutch | |
| Micro model | 31/12/2020 | 07/05/2021 | 05/07/2021 | Dutch | |
| Micro model | 31/12/2019 | 04/05/2020 | 14/05/2020 | Dutch | |
| Micro model | 31/12/2018 | 29/01/2019 | 15/02/2019 | Dutch | |
| Micro model | 31/12/2017 | 13/02/2018 | 20/02/2018 | Dutch | |
| Micro model | 31/12/2016 | 02/03/2017 | 24/04/2017 | Dutch | |
| Abridged model | 31/12/2015 | 24/02/2016 | 24/03/2016 | Dutch | |
| Abridged model | 31/12/2014 | 02/02/2015 | 26/02/2015 | Dutch | |
| Abridged model | 31/12/2013 | 24/03/2014 | 26/03/2014 | Dutch | |
| Abridged model | 31/12/2012 | 03/05/2013 | 23/07/2013 | Dutch | |
| Abridged model | 31/12/2011 | 04/05/2012 | 06/08/2012 | Dutch | |
| Abridged model | 31/12/2010 | 30/06/2011 | 26/07/2011 | Dutch | |
| Abridged model | 31/12/2009 | 30/06/2010 | 31/08/2010 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Christel Thomassen | DirectorManager2019 accountsended | ||
Erik Maes | DirectorManager2019 accountsended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings17 filings
Mandates
Erik Maes
Christel Thomassen
200920102011201220132014201520162017201820192020202120222023202420252026
Medimax
Caetsbeek 23, 3600 Genk
Director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Caetsbeek 23, 3600 GenkCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00078203 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| MedimaxCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00078203 |
Events
- 2025Annual accounts 202541,1 k €↑
- 2024Annual accounts 202417,4 k €↑
- 2023Annual accounts 2023-6,2 k €↓
- 2022Annual accounts 202233,4 k €↑
- 2021Annual accounts 202114,5 k €↓
- 2020Annual accounts 202017 k €↓
- 2019Annual accounts 201917,6 k €↑
- 2018Annual accounts 201811,7 k €↓
- 2017Annual accounts 201720,3 k €↑
- 2016Annual accounts 201610,2 k €↓
- 2015Annual accounts 201512,5 k €↓
- 2014Annual accounts 201424,1 k €↑
- 2013Annual accounts 201310 k €↓
- 2012Annual accounts 201228,7 k €↑
- 2011Annual accounts 20111,7 k €↓
- 2010Annual accounts 20107 k €↓
- 2009Annual accounts 200926,4 k €
- 02/04/2009IncorporationPrivate limited company